1. Mroueh, M. Saab, Y. Rizkallah, R.:Hepatoprotective activity of Centauriumerythraea on acetaminophen-induced hepatotoxicity in rats. Phytother. Res.,2004;18, 431–433.
2. Shalizar Jalali, A. Hassanzadeh, Sh. Malekinejad, H., Chemoprotective effect of Crataegus monogyna aqueous extract against cyclophosphamide- induced reproductive toxicity. Veterinary Research Forum 2011; 2 (4) 266- 273.
3. Ludeman SM. The chemistry of the metabolites of cyclophosphamide.Curr Pharm Des., 1999; 5: 627–643
4. Kern, JC.Kehrer,JP.:Acroleininduced cell death: a caspase influenced decision between apoptosis and oncosis/necrosis. ChemBiol Interact., 2002; 139: 79– 95.
5. Anderson, D. Bishop, JB. Garner, RC. et al. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutat Res., 1995; 330: 115– 181.
6. Fulya, U., Feraye, E., Atila, A., Protective effect of Salvia offi cinalis extract against cyclophosphamide-induced genotoxicity and oxidative stress in rats. Turk. J. vet. Anim 2012; 36(6): 646-654.
7. Kopecna, L.: Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia Bratisl. Lek.Listy., 2001; 102: 357–360.
8. Gustafsson, L.L. Eriksson, L.S. Dahl, M.L. Eleborg, L. Ericzon, B.G. Nyberg, A.: Cyclophosphamide-induced acute liver failure requiring transplantation in a patient with genetically deficientdebrisoquine metabolism: a causal relationship? J. Intern. Med., 1996; 240: 311– 314.
9. Madle, E. Korte, A. Beek, B.: Species diff erences in mutagenicity testing. II. Sisterchromatid exchange and micronucleus induction in rats, mice and Chinese hamsters treated with cyclophosphamide. Mutagenesis., 1986; 1: 419–422.
10. Giesy, J.P., Kong, Z., Cui, Y. Protective effects of eicosapentaenoic acid on genotoxicity and oxidative stress of cyclophosphamide in mice. Environ. Toxicol 2011; 26: 217– 223.
11. Todorova, V. Vanderpool, D. Blossom, S. Nwokedi, E. Hennings, L. Mrak, R.Klimberg, V.S.: Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione. Nutrition., 2009; 25: 812–817.
12. Grzegorczyk, I. Matkowski, A. Wysokinska, H.: Antioxidant activity of extracts from in vitro cultures of Salvia officinalis L. Food Chem., 2007; 104: 536–541.
13. Weisburger, J.H.: Antimutagenesis and anticarcinogenesis from the past to the future. Mutat. Res., 2001; 480-481: 23–35.
14. Pimenov, M. G. &Leonov, M. V.: The Asian Umbelliferae biodiversity database (ASIUM) with particular reference to SouthWest Asian Taxa. Turkish Journal of Botany.,2004;28, 139–145.
15. Firuzi, o. Asadollahi, M. Gholami, M. Javidnia, K. Composition and biological activities of essential oils from four Heracleum specie. Food Chemistry 2010; 122: 117–122.
16. Amin, G., Popular medicinal plants of Iran. Tehran: Tehran University of Medical Sciences Press 2008; 42:396-399.
17. Ghodsi, B.: Flavonoids of three Heracleum species: H. Persicum L, H. sphondylium L. and H. montanum. Bull. TravSoc Pharm Lyon., 1976; 20: 3-8.
18. Souri, F.Farsam, H.Sarkheil, P.Ebadi,F.: Antioxidant activity of some furanocoumarins isolated from Heracleumpersicum. Pharm Biol., 2004; 42: 396-399.
19. Dehghan, G.Shafiee, A.Ghahremani, M.Ardestani, S.Abdollahi,M.: Antioxidant potential of various extracts from Ferula szovitsiana in relation to their phenolic contents. Pharm Biol., 2007; Vol. 45: No. 9, pp. 1– 9.
20. Diana Anderson ap JBBb, R. Colin Garner, Patricia OstroskyWegman d., Selby PB.; Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks. Mutation Research 1995; 330: 115-181.
21. Shahrani M, nabavizadeh F, Shirzad H, yousefi H, Moradi M T, Moghadasi J. effect of Heracleum persicum extract on acid and pepsin secretion level in both basic and stimulated conditions with pentagastrin in rat. J Shahrekord univ Med Sci. 2006; 7 (4) : 35-41.
22. bi, H.: Catalase in vitro. Methods Enzymol., 1984; 105: 121–126.
23. Winterbourn, C. Hawkins, R. Brian, M.Carrell, R.: The estimation of red cell superoxide dismutase activity. J Lab Clin Med., 1975; 85: 337.
24. McDiarmid, MA.Iype, PT.Koldner, K.Jacobnson, KD. Strickland, PT.: Evidence for acrolein-modified DNA in peripheral blood leucocytes of cancer patients treated with cyclophosphamide.,1991.
25. Lahouel, M.Fillastre,JP.:Role of flavonoids in the prevention of haematoxicity due to chemotherapeutic agents. Haema.,2004;7:313–320.
26. Patel, J.M. Block, E.R.: Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp. Lung Res., 1985; 8: 153–165.
27. Kumar, G.Banu, SG.Kannan, V.Pandian,RM.: Antihepatotoxic effect of β-carotene on paracetamol induced hepatic damage in rats. Ind J Exp Biol., 2005; 43:351–355
28. Searle, AJ. Wilson, RL.:Glutathione peroxidase: effect of superoxide, hydroxyl and bromine free radicals on enzymicactivity. Int J Radi Biol., 1980; 37: 213.
29. Mahmoud, AM. Hussein, OE. Ramadan, SA.Amelioration of cyclophosphamide-induced hepatotoxicity by the brown seaweed Turbenariaornata.Int J ClinToxicol.,2013;1:9–17 Mutat Res 248:93–99.
30. Rajasekaran, N.S. Devaraj, H.Devaraj, S.N.: The effect of glutathione monoester (GME) on glutathione (GSH) depleted rat liver. J NutrBiochem., 2002; 13:302-306.
31. Tripathi, D.N. Jena, G.B.: Intervention of astaxanthin against cyclophosphamide-induced oxidative stress and DNA damage: a study in mice. ChemBiol Interact., 2009; 180: 398-406.
32. Atefeh, H.Mahnaz, A. and S, Abdolhamid, A.: Medicinal Effect of Heracleumpercicum (Golpar). Middle-EastJournal of Scientific Research., 2010; 5 (3): 174-176.
33. Oboh, G.Akomolafe, LT.Adefegha, AT.Adetuyi, OA. Inhibition of cyclophosphamide induced oxidative stress in rat brain by polar and non-polar extracts of Annatto (Bixaorellana) seeds. ExpToxicolPathol., 2011;63:257– 62.
34. Abe, K. Saito, H. Effect of Saffron extract and its constituent crocin on learning behavior and long-term potentiation.Phytotherapy Research.,2000; 14(3): 149-152.